A global bioscience company dedicated to healthy aging.
Location: United States, California, Los Angeles
Employees: 51-200
Phone: +1 310-388-6706
Total raised: $5M
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | DSM | dsm.com |
| - | DSM Ventur... | venturing.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.10.2022 | - | $5M | - |
Mentions in press and media 14
| Date | Title | Description |
| 09.10.2025 | RevGenetics Celebrates FDA's Landmark Reversal on NMN, Affirming Its Status as a Lawful Dietary Supplement | Company's 2014-2016 market evidence helped secure consumer access to advanced NAD+ precursor technology MIAMI, Oct. 9, 2025 /PRNewswire-PRWeb/ -- RevGenetics, a pioneer in longevity and anti-aging supplements, today celebrates the U.S. Food... |
| 30.09.2025 | Facing Centuries in Prison, Andrew Left Heads to Trial — Will Justice Finally Come for Barry Honig and Others? | Share Share Share Share Email Facing Centuries in Prison, Andrew Left Heads to Trial — Will Justice Finally Come for Barry Honig and Others? The criminal charges against Citron Research founder Andrew Left mark a spectacular reversal of for... |
| 31.08.2024 | The Fork in the Road: Navigating Food Innovation and Regulation | In the landscape of modern food production, two contrasting narratives are unfolding. On one side, we have the push for healthier options through regulation of ultra-processed foods (UPFs). On the other, a backlash against cultivated meat t... |
| 30.08.2024 | Op Ed: Frank Jaksch, CEO of Ayana Bio – Regulation of Ultra Proccessed Foods, Navigating Potential Paths Forward | Frank Jaksch is the CEO of Ayana Bio, the Boston-based company working on the production of cacao bioactives and agriculture-free saffron amongst other developments. Ayana Bio is one of an emerging group of plant cell cultivation tech firms... |
| 12.10.2022 | How This Global Bioscience Company Got Innovative With Research And Saved Millions | Research and development (R&D) is a massive expense for companies. When a company can find cost-effective ways to save money without compromising quality or credibility, it is news worth sharing. |
| 03.11.2021 | ChromaDex Corporation Reports Third Quarter 2021 Financial Results - Form 8-K | ChromaDex Corporation Reports Third Quarter 2021 Financial Results Total company net sales of $17.3 million for the three months ended September 30, 2021, with Tru Niagen® net sales of $14.8 million, up 24% from the prior year quarter and g... |
| 18.03.2021 | ChromaDex to Present at the Zooming with LD Virtual Investor Conference | LOS ANGELES--(BUSINESS WIRE)--Mar 18, 2021-- ChromaDex Corp. (NASDAQ:CDXC) today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Kevin Farr, will be presenting virtually at the Zooming with LD investor co... |
| 10.03.2021 | ChromaDex Announces Retail Distribution of Tru Niagen® in Walmart Stores Across the United States | LOS ANGELES--(BUSINESS WIRE)--Mar 10, 2021-- ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product and industry-leading NAD + booster Tru Niagen® will be available in 3,000 Walmart retail stores across the United State... |
| 10.03.2021 | ChromaDex Corporation Reports 2020 Financial Results | LOS ANGELES--(BUSINESS WIRE)--Mar 10, 2021-- ChromaDex Corp. (NASDAQ:CDXC) today reported fourth quarter and full year 2020 financial results. Fourth Quarter 2020 and Recent Highlights Total net sales of $15.4 million, up 18% from $13.1 mil... |
| 09.03.2021 | ChromaDex to Present at Oppenheimer 31st Annual Healthcare Conference | LOS ANGELES--(BUSINESS WIRE)--Mar 9, 2021-- ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31 st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT). A... |
Show more